Comparison of Characteristics of Future Myocardial Infarctions in Women With Baseline High Versus Baseline Low Levels of High-Sensitivity C-Reactive Protein

While the research is plentiful, the concept that inflammation is a major player in CVD has been slow to catch on. This study is just another that adds to the research, with some additional tidbits added in. The higher the hsCRP levels, the sooner healthy women had heart attacks and the more likely these women were to experience a fatal heart attack. The real kick in the glut region is that the use of statin drugs to lower cholesterol probably is not having its impact on CVD risk via cholesterol, but rather by acting as an anti-inflammatory.

However, there are many other, much more potent, means of lowering inflammation that don’t involve medications that lower levels of CoQ10, an absolutely essential nutrient for healthy cell function.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.